[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Human Coagulation Factor VIII Market Report 2017

December 2017 | 97 pages | ID: UD7887386C5EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Human Coagulation Factor Ⅷ market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Human Coagulation Factor Ⅷ in these regions, from 2012 to 2022 (forecast).
United States Human Coagulation Factor Ⅷ market competition by top manufacturers/players, with Human Coagulation Factor Ⅷ sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • CSL Behring
  • Baxter
  • Grifols
  • Octapharma
  • Zhongsheng Group
  • Taibang Bio
  • Shanghai Laishi
  • Hualan Bio
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Injection
  • Freeze-dried Injection
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hemophilia A
  • Relvent Bleeding Diseases
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Human Coagulation Factor Ⅷ Market Report 2017

1 HUMAN COAGULATION FACTOR Ⅷ OVERVIEW

1.1 Product Overview and Scope of Human Coagulation Factor Ⅷ
1.2 Classification of Human Coagulation Factor Ⅷ by Product Category
  1.2.1 United States Human Coagulation Factor Ⅷ Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Human Coagulation Factor Ⅷ Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Injection
  1.2.4 Freeze-dried Injection
1.3 United States Human Coagulation Factor Ⅷ Market by Application/End Users
  1.3.1 United States Human Coagulation Factor Ⅷ Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hemophilia A
  1.3.3 Relvent Bleeding Diseases
1.4 United States Human Coagulation Factor Ⅷ Market by Region
  1.4.1 United States Human Coagulation Factor Ⅷ Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Human Coagulation Factor Ⅷ Status and Prospect (2012-2022)
  1.4.3 Southwest Human Coagulation Factor Ⅷ Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Human Coagulation Factor Ⅷ Status and Prospect (2012-2022)
  1.4.5 New England Human Coagulation Factor Ⅷ Status and Prospect (2012-2022)
  1.4.6 The South Human Coagulation Factor Ⅷ Status and Prospect (2012-2022)
  1.4.7 The Midwest Human Coagulation Factor Ⅷ Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Human Coagulation Factor Ⅷ (2012-2022)
  1.5.1 United States Human Coagulation Factor Ⅷ Sales and Growth Rate (2012-2022)
  1.5.2 United States Human Coagulation Factor Ⅷ Revenue and Growth Rate (2012-2022)

2 UNITED STATES HUMAN COAGULATION FACTOR Ⅷ MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Human Coagulation Factor Ⅷ Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Human Coagulation Factor Ⅷ Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Human Coagulation Factor Ⅷ Average Price by Players/Suppliers (2012-2017)
2.4 United States Human Coagulation Factor Ⅷ Market Competitive Situation and Trends
  2.4.1 United States Human Coagulation Factor Ⅷ Market Concentration Rate
  2.4.2 United States Human Coagulation Factor Ⅷ Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Human Coagulation Factor Ⅷ Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HUMAN COAGULATION FACTOR Ⅷ SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Human Coagulation Factor Ⅷ Sales and Market Share by Region (2012-2017)
3.2 United States Human Coagulation Factor Ⅷ Revenue and Market Share by Region (2012-2017)
3.3 United States Human Coagulation Factor Ⅷ Price by Region (2012-2017)

4 UNITED STATES HUMAN COAGULATION FACTOR Ⅷ SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Human Coagulation Factor Ⅷ Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Human Coagulation Factor Ⅷ Revenue and Market Share by Type (2012-2017)
4.3 United States Human Coagulation Factor Ⅷ Price by Type (2012-2017)
4.4 United States Human Coagulation Factor Ⅷ Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HUMAN COAGULATION FACTOR Ⅷ SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Human Coagulation Factor Ⅷ Sales and Market Share by Application (2012-2017)
5.2 United States Human Coagulation Factor Ⅷ Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HUMAN COAGULATION FACTOR Ⅷ PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 CSL Behring
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Coagulation Factor Ⅷ Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 CSL Behring Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Baxter
  6.2.2 Human Coagulation Factor Ⅷ Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Baxter Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Grifols
  6.3.2 Human Coagulation Factor Ⅷ Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Grifols Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Octapharma
  6.4.2 Human Coagulation Factor Ⅷ Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Octapharma Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Zhongsheng Group
  6.5.2 Human Coagulation Factor Ⅷ Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Zhongsheng Group Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Taibang Bio
  6.6.2 Human Coagulation Factor Ⅷ Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Taibang Bio Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Shanghai Laishi
  6.7.2 Human Coagulation Factor Ⅷ Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Shanghai Laishi Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Hualan Bio
  6.8.2 Human Coagulation Factor Ⅷ Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Hualan Bio Human Coagulation Factor Ⅷ Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 HUMAN COAGULATION FACTOR Ⅷ MANUFACTURING COST ANALYSIS

7.1 Human Coagulation Factor Ⅷ Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Coagulation Factor Ⅷ

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Coagulation Factor Ⅷ Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Coagulation Factor Ⅷ Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HUMAN COAGULATION FACTOR Ⅷ MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Human Coagulation Factor Ⅷ Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Human Coagulation Factor Ⅷ Sales Volume Forecast by Type (2017-2022)
11.3 United States Human Coagulation Factor Ⅷ Sales Volume Forecast by Application (2017-2022)
11.4 United States Human Coagulation Factor Ⅷ Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Human Coagulation Factor Ⅷ
Figure United States Human Coagulation Factor Ⅷ Market Size (K Units) by Type (2012-2022)
Figure United States Human Coagulation Factor Ⅷ Sales Volume Market Share by Type (Product Category) in 2016
Figure Injection Product Picture
Figure Freeze-dried Injection Product Picture
Figure United States Human Coagulation Factor Ⅷ Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Human Coagulation Factor Ⅷ by Application in 2016
Figure Hemophilia A Examples
Table Key Downstream Customer in Hemophilia A
Figure Relvent Bleeding Diseases Examples
Table Key Downstream Customer in Relvent Bleeding Diseases
Figure United States Human Coagulation Factor Ⅷ Market Size (Million USD) by Region (2012-2022)
Figure The West Human Coagulation Factor Ⅷ Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Human Coagulation Factor Ⅷ Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Human Coagulation Factor Ⅷ Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Human Coagulation Factor Ⅷ Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Human Coagulation Factor Ⅷ Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Human Coagulation Factor Ⅷ Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Coagulation Factor Ⅷ Sales (K Units) and Growth Rate (2012-2022)
Figure United States Human Coagulation Factor Ⅷ Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Coagulation Factor Ⅷ Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Human Coagulation Factor Ⅷ Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Human Coagulation Factor Ⅷ Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Coagulation Factor Ⅷ Sales Share by Players/Suppliers
Figure 2017 United States Human Coagulation Factor Ⅷ Sales Share by Players/Suppliers
Figure United States Human Coagulation Factor Ⅷ Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Human Coagulation Factor Ⅷ Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Human Coagulation Factor Ⅷ Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Coagulation Factor Ⅷ Revenue Share by Players/Suppliers
Figure 2017 United States Human Coagulation Factor Ⅷ Revenue Share by Players/Suppliers
Table United States Market Human Coagulation Factor Ⅷ Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Human Coagulation Factor Ⅷ Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Human Coagulation Factor Ⅷ Market Share of Top 3 Players/Suppliers
Figure United States Human Coagulation Factor Ⅷ Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Human Coagulation Factor Ⅷ Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Human Coagulation Factor Ⅷ Product Category
Table United States Human Coagulation Factor Ⅷ Sales (K Units) by Region (2012-2017)
Table United States Human Coagulation Factor Ⅷ Sales Share by Region (2012-2017)
Figure United States Human Coagulation Factor Ⅷ Sales Share by Region (2012-2017)
Figure United States Human Coagulation Factor Ⅷ Sales Market Share by Region in 2016
Table United States Human Coagulation Factor Ⅷ Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Human Coagulation Factor Ⅷ Revenue Share by Region (2012-2017)
Figure United States Human Coagulation Factor Ⅷ Revenue Market Share by Region (2012-2017)
Figure United States Human Coagulation Factor Ⅷ Revenue Market Share by Region in 2016
Table United States Human Coagulation Factor Ⅷ Price (USD/Unit) by Region (2012-2017)
Table United States Human Coagulation Factor Ⅷ Sales (K Units) by Type (2012-2017)
Table United States Human Coagulation Factor Ⅷ Sales Share by Type (2012-2017)
Figure United States Human Coagulation Factor Ⅷ Sales Share by Type (2012-2017)
Figure United States Human Coagulation Factor Ⅷ Sales Market Share by Type in 2016
Table United States Human Coagulation Factor Ⅷ Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Human Coagulation Factor Ⅷ Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Coagulation Factor Ⅷ by Type (2012-2017)
Figure Revenue Market Share of Human Coagulation Factor Ⅷ by Type in 2016
Table United States Human Coagulation Factor Ⅷ Price (USD/Unit) by Types (2012-2017)
Figure United States Human Coagulation Factor Ⅷ Sales Growth Rate by Type (2012-2017)
Table United States Human Coagulation Factor Ⅷ Sales (K Units) by Application (2012-2017)
Table United States Human Coagulation Factor Ⅷ Sales Market Share by Application (2012-2017)
Figure United States Human Coagulation Factor Ⅷ Sales Market Share by Application (2012-2017)
Figure United States Human Coagulation Factor Ⅷ Sales Market Share by Application in 2016
Table United States Human Coagulation Factor Ⅷ Sales Growth Rate by Application (2012-2017)
Figure United States Human Coagulation Factor Ⅷ Sales Growth Rate by Application (2012-2017)
Table CSL Behring Basic Information List
Table CSL Behring Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CSL Behring Human Coagulation Factor Ⅷ Sales Growth Rate (2012-2017)
Figure CSL Behring Human Coagulation Factor Ⅷ Sales Market Share in United States (2012-2017)
Figure CSL Behring Human Coagulation Factor Ⅷ Revenue Market Share in United States (2012-2017)
Table Baxter Basic Information List
Table Baxter Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Baxter Human Coagulation Factor Ⅷ Sales Growth Rate (2012-2017)
Figure Baxter Human Coagulation Factor Ⅷ Sales Market Share in United States (2012-2017)
Figure Baxter Human Coagulation Factor Ⅷ Revenue Market Share in United States (2012-2017)
Table Grifols Basic Information List
Table Grifols Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Grifols Human Coagulation Factor Ⅷ Sales Growth Rate (2012-2017)
Figure Grifols Human Coagulation Factor Ⅷ Sales Market Share in United States (2012-2017)
Figure Grifols Human Coagulation Factor Ⅷ Revenue Market Share in United States (2012-2017)
Table Octapharma Basic Information List
Table Octapharma Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Octapharma Human Coagulation Factor Ⅷ Sales Growth Rate (2012-2017)
Figure Octapharma Human Coagulation Factor Ⅷ Sales Market Share in United States (2012-2017)
Figure Octapharma Human Coagulation Factor Ⅷ Revenue Market Share in United States (2012-2017)
Table Zhongsheng Group Basic Information List
Table Zhongsheng Group Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Zhongsheng Group Human Coagulation Factor Ⅷ Sales Growth Rate (2012-2017)
Figure Zhongsheng Group Human Coagulation Factor Ⅷ Sales Market Share in United States (2012-2017)
Figure Zhongsheng Group Human Coagulation Factor Ⅷ Revenue Market Share in United States (2012-2017)
Table Taibang Bio Basic Information List
Table Taibang Bio Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Taibang Bio Human Coagulation Factor Ⅷ Sales Growth Rate (2012-2017)
Figure Taibang Bio Human Coagulation Factor Ⅷ Sales Market Share in United States (2012-2017)
Figure Taibang Bio Human Coagulation Factor Ⅷ Revenue Market Share in United States (2012-2017)
Table Shanghai Laishi Basic Information List
Table Shanghai Laishi Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shanghai Laishi Human Coagulation Factor Ⅷ Sales Growth Rate (2012-2017)
Figure Shanghai Laishi Human Coagulation Factor Ⅷ Sales Market Share in United States (2012-2017)
Figure Shanghai Laishi Human Coagulation Factor Ⅷ Revenue Market Share in United States (2012-2017)
Table Hualan Bio Basic Information List
Table Hualan Bio Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hualan Bio Human Coagulation Factor Ⅷ Sales Growth Rate (2012-2017)
Figure Hualan Bio Human Coagulation Factor Ⅷ Sales Market Share in United States (2012-2017)
Figure Hualan Bio Human Coagulation Factor Ⅷ Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Coagulation Factor Ⅷ
Figure Manufacturing Process Analysis of Human Coagulation Factor Ⅷ
Figure Human Coagulation Factor Ⅷ Industrial Chain Analysis
Table Raw Materials Sources of Human Coagulation Factor Ⅷ Major Players/Suppliers in 2016
Table Major Buyers of Human Coagulation Factor Ⅷ
Table Distributors/Traders List
Figure United States Human Coagulation Factor Ⅷ Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Human Coagulation Factor Ⅷ Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Human Coagulation Factor Ⅷ Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Human Coagulation Factor Ⅷ Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Human Coagulation Factor Ⅷ Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Human Coagulation Factor Ⅷ Sales Volume (K Units) Forecast by Type in 2022
Table United States Human Coagulation Factor Ⅷ Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Human Coagulation Factor Ⅷ Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Human Coagulation Factor Ⅷ Sales Volume (K Units) Forecast by Application in 2022
Table United States Human Coagulation Factor Ⅷ Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Human Coagulation Factor Ⅷ Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Coagulation Factor Ⅷ Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Coagulation Factor Ⅷ Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories